Preserve the brain: Primary goal in the therapy of atrial fibrillation

Journal of the American College of Cardiology

Volumn 62, Issue 6, 2013, Pages 540-542

  Prystowsky, Eric N ^a   Padanilam, Benzy J ^a  

^a ST VINCENT HOSPITAL   (United States)

Author keywords

ablation; atrial fibrillation; neurocognitive dysfunction; outcomes

Indexed keywords

ANTICOAGULANT AGENT; DABIGATRAN; ENOXAPARIN; RIVAROXABAN; WARFARIN;

ALZHEIMER DISEASE; ANTICOAGULANT THERAPY; ARTIFICIAL HEART PACEMAKER; BRAIN EMBOLISM; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CLINICAL EVALUATION; COGNITIVE DEFECT; DEFIBRILLATION; DRUG EFFICACY; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; NEUROIMAGING; NEUROPROTECTION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; VASCULAR ACCESS;

EID: 84881103873     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.04.038     Document Type: Editorial

References (29)

1. V. Fuster, L.E. Rydén, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 48 2006 854 906
2. S.J. Connolly, M.B. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
3. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
4. C.B. Granger, J.F. Alexander, and J.J.V. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
5. D. Poli, G.Y.H. Lip, E. Antonucci, E. Grifoni, and D. Lane Stroke risk stratification in a "real world" elderly anticoagulated atrial fibrillation population J Cardiovasc Electrophysiol 22 2011 25 30
6. L. Kilander, B. Andren, H. Nyman, L. Lind, M. Boberg, and H. Lithell Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men Stroke 29 1998 1816 1820
7. S. Knecht, C. Oelschlager, and T. Duning Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy Eur Heart J 29 2008 2125 2132
8. T.J. Bunch, J.P. Weiss, and B.G. Crandall Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia Heart Rhythm 7 2010 433 437
9. T.J. Bunch, B.G. Crandall, and P. Weiss Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation J Cardiovasc Electrophysiol 22 2011 839 845
10. M.M. Mielke, P.B. Rosenberg, and J. Tschanz Vascular factors predict rate of progression in Alzheimer disease Neurology 69 2007 1850 1858
11. G. Nichols, K. Reinier, and S. Chugh Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation Diabetes Care 32 2009 1851 1856
12. R.R. Huxley, K.B. Filion, S. Konety, and A. Alonso Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation Am J Cardiol 108 2011 56 62
13. H. Calkins, K.H. Kuck, and R. Cappato 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design Heart Rhythm 9 2012 632 696
14. F. Gaita, D. Caponi, and M.N. Pianelli Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation Circulation 122 2010 1667 1673
15. C.H. Siklody, T. Deneke, and M. Hocini Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation J Am Coll Cardiol 58 2011 681 688
16. K.G. Haeusler, L. Koch, and J. Herm 3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study J Cardiovasc Electrophysiol 24 2013 14 21
17. G.L. Botto, L. Padeletti, and M. Santini Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events J Cardiovasc Electrophysiol 20 2009 241 248
18. J.S. Healey, S.J. Connolly, and M.R. Gold Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
19. J. Engdahl, L. Andersson, M. Mirskaya, and M. Rosenqvist Stepwise screening of atrial fibrillation in a 75-year old population Circulation 127 2013 930 937
20. G. Hindricks, C. Piorkowski, and H. Tanner Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence Circulation 112 2005 307 313
21. R. Marfella, F.C. Sasso, and M. Siniscalchi Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients J Am Coll Cardiol 62 2013 525 530
22. C. Medi, L. Evered, and B. Silbert Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation J Am Coll Cardiol 62 2013 531 539
23. M.F. Newmann, J.L. Kirchner, and B. Phillips-Bute Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery N Engl J Med 344 2001 395 402
24. N. Schwarz, M. Kuniss, and M. Nedelmann Neuropsychological decline after catheter ablation of atrial fibrillation Heart Rhythm 7 2010 1761 1767
25. The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
26. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker Comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
27. R. Ionescu-Ittu, M. Abrahamowicz, and C.A. Jackevicius Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation Arch Intern Med 172 2012 997 1004
28. M.A. Tsadok, Jackevicius, and V. Essebag Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation Circulation 126 2012 2680 2687
29. L.A. Saxon Ubiquitous wireless ECG recording: a powerful tool physicians should embrace J Cardiovasc Electrophysiol 24 2013 480 483